scholarly journals p57KIP2 regulates radial glia and intermediate precursor cell cycle dynamics and lower layer neurogenesis in developing cerebral cortex

Development ◽  
2012 ◽  
Vol 139 (3) ◽  
pp. 475-487 ◽  
Author(s):  
G. Mairet-Coello ◽  
A. Tury ◽  
E. Van Buskirk ◽  
K. Robinson ◽  
M. Genestine ◽  
...  
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Corinne L. A. Fairchild ◽  
Simranjeet K. Cheema ◽  
Joanna Wong ◽  
Keiko Hino ◽  
Sergi Simó ◽  
...  

An amendment to this paper has been published and can be accessed via a link at the top of the paper.


2021 ◽  
Author(s):  
◽  
Timothy John Sargeant

<p>Opiate drugs, such as codeine, morphine and heroin are powerful analgesics and drugs of abuse. The unborn child is invariably exposed to opiate drugs as a consequence of maternal use. Studies that have investigated the impact of opiate drugs demonstrated opioid system expression in proliferating regions of the developing brain, as well as on proliferative astroglia taken from the developing central nervous system. The effects of opiates on astroglial proliferation (largely mediated by the mu opioid receptor) are predominantly inhibitory, but are extremely context dependent. This context dependency exists because of the complexity resident within the opioid signalling system. However, since this previous research was conducted, there has been impressive progress made in the field of developmental neurobiology with the demonstration that cells of astrocytic lineage are responsible for the generation of the central nervous system. It was therefore the aim of the current research project to investigate the developmental impact of opiate exposure in the context of the foetal mouse cerebral cortex. This aim was divided into 3 separate aims that comprised of; determining the cellular localisation of the mu opioid receptor, the effects of opiate exposure on cortical progenitor cells, and to determine the effect of opiate exposure on the development of the cerebral cortex itself. The mu opioid receptor was expressed on proliferative radial glia of both the embryonic day 15.5 (neurogenic) and embryonic day 18.5 (gliogenic) ventricular zone of the dorsal forebrain. Interestingly and significantly, the mu opioid receptor-positive glia observed in the embryonic day 18.5 mouse forebrain were also observed at a comparable developmental stage in the foetal human forebrain. Morphine exposure slowed down G2 phase of the cell cycle at embryonic day 15.5 in the neurogenic murine cortical ventricular zone. This opiate-induced slowing in cell cycle progression was shown not to impact on proliferation in the ventricular zone, although future research should address whether this perturbation altered differentiation or developmental maturation of the radial glia. Morphine exposure throughout corticogenesis decreased levels of doublecortin expression (a migratory neuronal marker) at the end of gestation. Postnatally, mice exposed to morphine during corticogenesis also showed decreased numbers of neurons in layer V of the cerebral cortex. Collectively, this thesis presents the first evidence that shows morphine affects cortical progenitor cells in vivo. This research supports the possibility that the opioid system plays an endogenous role in corticogenesis. The clinical significance is morphine has the potential to perturb normal development of the cerebral cortex.</p>


2021 ◽  
Author(s):  
◽  
Timothy John Sargeant

<p>Opiate drugs, such as codeine, morphine and heroin are powerful analgesics and drugs of abuse. The unborn child is invariably exposed to opiate drugs as a consequence of maternal use. Studies that have investigated the impact of opiate drugs demonstrated opioid system expression in proliferating regions of the developing brain, as well as on proliferative astroglia taken from the developing central nervous system. The effects of opiates on astroglial proliferation (largely mediated by the mu opioid receptor) are predominantly inhibitory, but are extremely context dependent. This context dependency exists because of the complexity resident within the opioid signalling system. However, since this previous research was conducted, there has been impressive progress made in the field of developmental neurobiology with the demonstration that cells of astrocytic lineage are responsible for the generation of the central nervous system. It was therefore the aim of the current research project to investigate the developmental impact of opiate exposure in the context of the foetal mouse cerebral cortex. This aim was divided into 3 separate aims that comprised of; determining the cellular localisation of the mu opioid receptor, the effects of opiate exposure on cortical progenitor cells, and to determine the effect of opiate exposure on the development of the cerebral cortex itself. The mu opioid receptor was expressed on proliferative radial glia of both the embryonic day 15.5 (neurogenic) and embryonic day 18.5 (gliogenic) ventricular zone of the dorsal forebrain. Interestingly and significantly, the mu opioid receptor-positive glia observed in the embryonic day 18.5 mouse forebrain were also observed at a comparable developmental stage in the foetal human forebrain. Morphine exposure slowed down G2 phase of the cell cycle at embryonic day 15.5 in the neurogenic murine cortical ventricular zone. This opiate-induced slowing in cell cycle progression was shown not to impact on proliferation in the ventricular zone, although future research should address whether this perturbation altered differentiation or developmental maturation of the radial glia. Morphine exposure throughout corticogenesis decreased levels of doublecortin expression (a migratory neuronal marker) at the end of gestation. Postnatally, mice exposed to morphine during corticogenesis also showed decreased numbers of neurons in layer V of the cerebral cortex. Collectively, this thesis presents the first evidence that shows morphine affects cortical progenitor cells in vivo. This research supports the possibility that the opioid system plays an endogenous role in corticogenesis. The clinical significance is morphine has the potential to perturb normal development of the cerebral cortex.</p>


2012 ◽  
Vol 365 (1) ◽  
pp. 189-195 ◽  
Author(s):  
Dennis A. Ridenour ◽  
Mary Cathleen McKinney ◽  
Caleb M. Bailey ◽  
Paul M. Kulesa

Development ◽  
1993 ◽  
Vol 118 (1) ◽  
pp. 175-192 ◽  
Author(s):  
S.E. Acklin ◽  
D. van der Kooy

A double-labeling technique, combining retroviral tagging of individual cell lines (one clone per brain hemisphere) with the simultaneous [3H]thymidine-labeling of dividing cells in S phase, was used to study proliferation characteristics of individual precursor cell lines in the germinal zone of the developing rat forebrain. The cortical germinal zone was found to be segregated into three spatially distinct horizontal populations of precursor cell lineages, which differed in cell cycle kinetics, amount of cell death, and synchronous versus asynchronous mode of proliferation. The striatal germinal zone demonstrated a similar heterogeneity in the cell cycle characteristics of proliferating clones, but did not show nearly as distinct a spatial segregation of these different populations. The results demonstrate the clonal heterogeneity among precursor populations in the telencephalon and the differential spatial organization of the cortical and the striatal germinal zones. This germinal zone heterogeneity may predict some of the differences found among cellular phenotypes in the adult forebrain.


2018 ◽  
Vol 3 (4) ◽  
pp. 35-37
Author(s):  
Arnab Ghosh ◽  
Diasma Ghartimagar ◽  
Sushma Thapa

Normal cell cycle and cell proliferation are regulated by several genes which can be broadly classified into 4 groups viz, proto-oncogenes, tumor suppressor genes, genes regulating apoptosis and genes involved in DNA repair. These genes may be defective due to different factors. The defective genes may lead to production of abnormal proteins which may lead to disruption of the normal cell cycle and proliferation. A single precursor cell with defective gene proliferates surpassing the normal physiologic regulatory process and leads to tumor formation, so, traditionally,it is said that “tumors are clonal”.


2009 ◽  
Vol 5 (3-4) ◽  
pp. 57-67 ◽  
Author(s):  
Konstantina Psachoulia ◽  
Francoise Jamen ◽  
Kaylene M. Young ◽  
William D. Richardson

Oligodendrocyte precursors (OLPs or ‘NG2 cells’) are abundant in the adult mouse brain, where they continue to proliferate and generate new myelinating oligodendrocytes. By cumulative BrdU labelling, we estimated the cell cycle timeTCand the proportion of NG2 cells that is actively cycling (the growth fraction) at ~ postnatal day 6 (P6), P60, P240 and P540. In the corpus callosum,TCincreased from <2 days at P6 to ~9 days at P60 to ~70 days at P240 and P540. In the cortex,TCincreased from ~2 days to >150 days over the same period. The growth fraction remained relatively invariant at ~50% in both cortex and corpus callosum – that is, similar numbers of mitotically active and inactive NG2 cells co-exist at all ages. Our data imply that a stable population of quiescent NG2 cells appears before the end of the first postnatal week and persists throughout life. The mitotically active population acts as a source of new oligodendrocytes during adulthood, while the biological significance of the quiescent population remains to be determined. We found that the mitotic status of adult NG2 cells is unrelated to their developmental site of origin in the ventral or dorsal telencephalon. We also report that new oligodendrocytes continue to be formed at a slow rate from NG2 cells even after P240 (8 months of age).


Sign in / Sign up

Export Citation Format

Share Document